enCore Energy Corp. filings document a British Columbia uranium issuer with common shares listed under EU on Nasdaq and the TSX Venture Exchange. Its 8-K reports cover operating and financial results, press-release exhibits, executive appointments and board changes, compensation-related agreements, and Regulation FD communications tied to corporate updates.
Proxy materials describe annual meeting procedures, director elections, governance and executive compensation matters. The company's formal disclosures also provide context on U.S. ISR uranium operations, capital structure items such as warrants and common shares, and shareholder matters connected with its uranium project portfolio and strategic holdings.
enCore Energy Corp. (EU) reported a Form 4 for Director William Harris detailing an equity grant. On October 8, 2025, he received 231,266 restricted stock units (RSUs), each representing the right to receive one common share.
The RSUs vest in two equal tranches: one-half on October 8, 2026 and one-half on October 8, 2027. Following the grant, 231,266 derivative securities were beneficially owned in direct form, with a reported price of $0 for the RSU grant.
enCore Energy Corp. director Dennis Stover was granted 200,133 restricted stock units (RSUs) on 10/08/2025. Each RSU represents the contingent right to receive one common share, and the award vests in two equal installments: one-half on 10/08/2026 and one-half on 10/08/2027. Following the grant, the reporting person beneficially owns 200,133 common shares on a direct basis. The Form 4 was signed by an attorney-in-fact on 10/10/2025. The grant carries a $0 purchase price and is disclosed under Section 16 reporting rules.
Susan Hoxie-Key, a director of enCore Energy Corp. (EU), was granted 175,133 restricted stock units on 10/08/2025. Each restricted stock unit represents the contingent right to receive one common share and the award carries a reported grant-date amount of $0 per unit. The RSUs vest in two equal installments: one-half on 10/08/2026 and one-half on 10/08/2027, and the reporting shows 175,133 common shares beneficially owned following the grant in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 10/10/2025.
enCore Energy Corp. (EU) reported an insider equity award for its Chief Financial Officer, Kevin Kremke. On 10/08/2025, he received 250,000 restricted stock units and 250,000 stock options.
The RSUs vest in four equal tranches on October 1 of 2026, 2027, 2028, and 2029. The options have a $3.47 exercise price, vest on the same schedule, and expire on 10/01/2030. These grants were reported as directly owned.
Kevin L. Kremke filed an Initial Statement of Beneficial Ownership (Form 3) reporting a relationship as Director and Chief Financial Officer of enCore Energy Corp. (EU). The filing, tied to a 10/01/2025 event date, discloses no securities beneficially owned by the reporting person. The form is signed by an attorney-in-fact, Robert Willette, dated 10/10/2025, and includes an Exhibit 24 power of attorney.
enCore Energy Corp. filed an S-3 shelf registration describing its business, corporate documents and disclosures incorporated by reference, and U.S./Canadian tax matters for holders of its common shares. The filing notes the company commenced uranium extraction in 2024 at the Rosita and Alta Mesa central processing plants in South Texas and describes a strategy to build ISR extraction capacity in South Texas with future exploration in South Dakota and Wyoming to supply domestic uranium for nuclear power.
The registration lists exhibits, legal opinions, auditor consents and technical-consultant consents, and references the 2024 Annual Report (Form 10-K filed March 3, 2025) and multiple subsequent SEC filings. The document also explains withholding tax rules for Non-Resident Holders (standard Canadian rates and reduced treaty rates of 15% and 5% in certain cases), U.S. PFIC rules, QEF and Mark-to-Market election mechanics, and backup withholding conditions.
enCore Energy Corp. appointed Janet Lee-Sheriff as Senior Vice President – Strategic Initiatives, effective October 6, 2025. The role adds senior leadership focused on the company’s strategic projects.
She will receive $150,000 in annual compensation, with an annual bonus opportunity and a sign-on package of restricted stock units and stock options. The company notes that Ms. Lee-Sheriff is the spouse of the Executive Chairman, highlighting a related-party relationship at the senior management level.
enCore Energy Corp. director William B. Harris reported the sale of 80,000 common shares on 10/07/2025 at a weighted-average price of $3.41 per share. After the transaction, the reporting person beneficially owns 280,001 shares in total. The filing was signed by an attorney-in-fact on 10/09/2025. The filing discloses the sale price range was $3.41 to $3.42 and offers to provide detailed per-trade quantities on request.
Director sale of common shares. A director, Dennis Stover, reported a sale of 20,000 common shares on 10/07/2025 at a reported price of $3.33 per share, leaving beneficial ownership of 488,500 shares. The sale code is listed as S (sale). The $3.33 price reflects a U.S. dollar conversion from a stated Canadian-dollar trade of $4.64 CAD using the Bank of Canada daily average rate of CAD$1.3951 per $1.00 on that date. The filing was signed by an attorney-in-fact and indicates the reporter is a director filing on an individual basis.
This Form 4 documents a routine insider sale and the remaining direct holding size; no options, warrants, or other derivative transactions are disclosed in the filing.
enCore Energy Corp. (EU) filed a Form 144 notice reporting a proposed sale of 80,000 common shares through Merrill One, Bryan Park, New York with an aggregate market value of $272,000. The filing shows the shares represent a small fraction of total shares outstanding (187,094,534). The securities were acquired by exercise of stock options: 3,333 shares on 10/05/2023 and 76,667 shares on 05/22/2024, with cash payment indicated for both. No sales by the reporting person are listed in the past three months. The approximate sale date is 10/07/2025. The filer certifies there is no undisclosed material adverse information and includes the required attestation language about trading plans and criminal penalties for misstatements.